Paola Cipriani

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

Oliver Distler, Angela Del Rosso, Roberto Giacomelli et al. · Arthritis Research & Therapy · 2002 · 278 citations · Full text

Ssc Patients, Vascular Disease, Immunology +21

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

Francesco Carubbi, Paola Cipriani, Alessandra Marrelli et al. · Arthritis Research & Therapy · 2013 · 175 citations · Full text

Immunology, Immunotherapy, Psoriatic Arthritis +23

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

Piero Ruscitti, Paola Cipriani, Francesco Masedu et al. · BMC Medicine · 2016 · 169 citations · Full text

Impairment of endothelial cell differentiation from bone marrow–derived mesenchymal stem cells: New insight into the pathogenesis of systemic sclerosis

Paola Cipriani, Serena Guiducci, Irene Miniati et al. · Arthritis & Rheumatism · 2007 · 152 citations

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1<b>β</b>via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

Piero Ruscitti, Paola Cipriani, Paola Di Benedetto et al. · Clinical & Experimental Immunology · 2015 · 131 citations · Full text